Post Tue Mar 12, 2024 4:40 pm

2024-Xiong et al-Signal Transduct Target Ther

"Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma"
Jie Xiong, Shu Cheng, Xiao Gao, Shan-He Yu, Yu-Ting Dai, Xin-Yun Huang, Hui-Juan Zhong, Chao-Fu Wang, Hong-Mei Yi, Hao Zhang, Wei-Guo Cao, Rong Li, Wei Tang, Yan Zhao, Peng-Peng Xu, Li Wang, Wei-Li Zhao
Signal Transduct Target Ther. 2024, 9, 62
https://doi.org/10.1038/s41392-024-01782-8

- no CyTOF dataset accession given